Finally, treatment with the MEK inhibitor U0126 suppressed the migratory and invasive abilities of ovarian carcinoma cells, indicating that these functions of GABRP are mediated via ERK pathway activation. This evidence concerns the gene MAP2K7 and ovarian carcinoma.